Akums Drugs and Pharmaceutical Market Cap ($1.21 Billion)
Market Cap & Net Worth: Akums Drugs and Pharmaceutical (AKUMS)
Akums Drugs and Pharmaceutical market cap. Akums Drugs and Pharmaceutical (NSE:AKUMS) has a market capitalization of $1.21 Billion (Rs112.25 Billion) as of November 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #7815 globally and #385 in its home market, demonstrating a 9.59% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Akums Drugs and Pharmaceutical's stock price Rs733.15 by its total outstanding shares 153102058 (153.10 Million). Also see Akums Drugs and Pharmaceutical cash flow conversion for how efficiently the company converts equity into cash flow.
Akums Drugs and Pharmaceutical Market Cap History (2024–2026)
Akums Drugs and Pharmaceutical market cap history from 2024 to 2026. Data shows change from $1.06 Billion to $1.21 Billion (-3.62% CAGR). Check AKUMS share price today for real-time trading data and today's change.
Index Memberships
Akums Drugs and Pharmaceutical is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY 500
NIFTY500
|
$2.99 Trillion | 0.04% | #309 of 500 |
|
NIFTY SMALLCAP 250
NISM250
|
$385.24 Billion | 0.32% | #124 of 250 |
Weight: Akums Drugs and Pharmaceutical's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Akums Drugs and Pharmaceutical Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Akums Drugs and Pharmaceutical's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of Akums Drugs and Pharmaceutical to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.03x
Akums Drugs and Pharmaceutical's market cap is 0.03 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.48x
Akums Drugs and Pharmaceutical's market cap is 0.48 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $1.06 Billion | $40.20 Billion | -$40.35 Million | 0.03x | N/A |
| 2025 | $750.71 Million | $40.71 Billion | $3.38 Billion | 0.02x | 0.22x |
| 2026 | $1.21 Billion | $43.59 Billion | $2.55 Billion | 0.03x | 0.48x |
Competitor Companies of AKUMS by Market Capitalization
Companies near Akums Drugs and Pharmaceutical in the global market cap rankings as of November 4, 2026. Also see total assets of Akums Drugs and Pharmaceutical for a full breakdown of the balance sheet.
Key companies related to Akums Drugs and Pharmaceutical by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #516 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #536 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #591 globally with a market cap of $45.45 Billion USD ( CN¥310.59 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #516 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #536 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.55 |
| #591 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.45 Billion | CN¥48.69 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Akums Drugs and Pharmaceutical (2024–2026)
Market capitalization of Akums Drugs and Pharmaceutical from 2024 to today. Between 2024 and today, Akums Drugs and Pharmaceutical's market cap moved from $1.06 Billion to $ 1.21 Billion, with a yearly change of -3.62%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs1.21 Billion | +61.70% |
| 2025 | Rs750.71 Million | -28.98% |
| 2024 | Rs1.06 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Akums Drugs and Pharmaceutical was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.21 Billion USD |
| MoneyControl | $1.21 Billion USD |
| MarketWatch | $1.21 Billion USD |
| marketcap.company | $1.21 Billion USD |
| Reuters | $1.21 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Akums Drugs and Pharmaceutical
Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. The company provides drugs, ayurvedic, nutraceuticals, food and dietary supplements, derma and cosmetics, healthcare and hospital products, over-the-counter (OTC) products, active pharmaceutical ingredients, excipients, and compounds. It also offe… Read more